Atacicept Completed Phase 2 Trials for Systemic Lupus Erythematosus (SLE) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01972568Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus